IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

Course on mapping human complex diseases

Tue Dec 19 15:13:43 EST 1995

                     *      COURSE ANNOUNCEMENT      *
                     *   GENETIC ANALYSIS METHODS    *
                     *   DEADLINE FOR APPLICATIONS   *
                     *      JANUARY 15, 1996         *

course directed toward physician scientists and/or other medical researchers. 
The course will introduce state-of-the-art approaches for the mapping of human
inherited disorders with an emphasis on the mapping of complex common diseases
phenotypes.  The overall focus of the course is on the development of a
broad-based knowledge of the application of Human Genome Initiative resources
to the design and execution of disease gene mapping projects.


The course is taught by an internationally renowned faculty of scientists and
physicians.  Each faculty member has extensive expertise in several course


Margaret A. Pericak-Vance, Ph.D., Department of Medicine, Department of
Genetics, Duke University School of Medicine.  She is a founding fellow of the
American College of Medical Genetics  and a board-certified Ph.D. medical
geneticist with fifteen years experience in genetic counseling.  Dr.
Pericak-Vance is a genetic epidemiologist whose research has focused on the
mapping of both simple mendelian and complex phenotypes of genetic disorders. 
She is actively mapping or has been involved in mapping such disorders as
amyotrophic lateral sclerosis (Lou Gehrig disease), tuberous sclerosis,
Alzheimer disease (AD), multiple sclerosis, primary open-angle glaucoma, and
age-related macular degeneration.

Jonathan L. Haines, Ph.D., Department of Neurology, Massachusetts General
Hospital, and Harvard Medical School.  Dr. Haines is a genetic epidemiologist
whose research has focused on both human disease and general (reference)
chromosome mapping.  Dr. Haines has been involved in mapping such diseases as
amyotrophic lateral sclerosis, Alzheimer disease, Huntington disease, tuberous
sclerosis, neurofibromatosis, multiple sclerosis, primary open- angle
glaucoma, and Batten disease.  


Arthur S. Aylsworth, M.D., Division of Genetics and Metabolism, Department of
Pediatrics, The University of North Carolina at Chapel Hill.  Dr. Aylsworth is
a board-certified pediatrician and clinical geneticist.  As a physician-
scientist, Dr. Aylsworth plays primary roles in family ascertainment and
phenotypic delineation.  He is actively involved in studies on
neurofibromatosis and neural tube defects.  

David Goldgar, Ph.D., Genetic Epidemiology, Department of Medical Informatics,
University of Utah.  Dr. Goldgar is a statistical geneticist with extensive
experience in both the theoretical and practical aspects of mapping human
quantitative and complex traits.  He has concentrated on the genetic
epidemiology of common cancers, focusing on the genetic mapping of breast and
ovarian cancer.

Marcy MacDonald, Ph.D., Department of Neurology, Massachusetts General
Hospital, and Harvard Medical School.  Dr. MacDonald is a molecular geneticist
with vast experience in applying molecular techniques to positional cloning
problems.  She has concentrated her efforts on the cloning and description of
the Huntington disease gene and other trinucleotide repeat disease genes.

Deborah A. Meyers, Ph.D., Department of Medicine, The Johns Hopkins
University.  Dr. Meyers is a statistical geneticist who has concentrated her
research on the genetic basis of complex disorders including allergy, and
psychiatric diseases such as schizophrenia and Alzheimer disease.  She has
extensive didactic experience in her teaching role at the short course in
Medical and Experimental and Mammalian Genetics, The Jackson Laboratory, Bar
Harbor, Maine.  

Marcy C. Speer, M.S., Ph.D., Department of Medicine, Duke University Medical
School.  Dr. Speer is a board-certified genetic counselor with twelve years of
experience.  She is also a genetic epidemiologist whose research interest is
in mapping human genetic diseases, including the muscular dystrophies and
neural tube defects. She is also involved in studies of unusual genetic
phenomena such as anticipation and imprinting.

Participation in the course will be dependent on completion of an application 
form that describes the applicant's background and research interests and is 
limited to 35 students.  All participants will need to show evidence of a 
postgraduate genetics course or its equivalent.  Participants must provide a 
brief statement describing their research interests, their reason for taking 
the course, and their long-term objectives in relation to the course
curriculum.  This information will be used to select a highly motivated
participant group.  Minority and women applicants are specifically encouraged
to apply.  A limited number of scholarships are available for registered
students or fellows. Scholarship selection will be based on the strength of
the individual applications. 

The course will be held at the Center for Executive Education on the campus
of Babson College just outside of Boston, MA, U.S.A.  It will be held from
April 14th-April 17th, 1996.  The total cost of the course is $1125.
The DEADLINE for completed applications is JANUARY 15, 1995. 

For more information, brochures, and application forms please contact:

                         Margaret A.  Pericak-Vance, Ph.D.
                         c/o Nadine Powers, Course Administrator
                         Duke University Medical Center, Box 2900
                         Durham, N.C.  27710
                         (919) 684-6274 (voice); or (919) 684-6514 (fax)
                         genclass at genemap.mc.duke.edu (email) or

More information about the Biochrom mailing list

Send comments to us at biosci-help [At] net.bio.net